A Phase II, multicenter, double blind, double dummy, randomized, 2 arms parallel study to evaluate the efficacy, safety and pharmacokinetics of CHF6563 in babies with Neonatal Opioid Withdrawal Syndrome
Clinical Trial Grant
Administered By
Pediatrics, Neonatology
Awarded By
Chiesi Farmaceutici SPA
Start Date
July 1, 2020
End Date
June 30, 2021
Administered By
Pediatrics, Neonatology
Awarded By
Chiesi Farmaceutici SPA
Start Date
July 1, 2020
End Date
June 30, 2021